Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Gonzalez Website

Frank J. Gonzalez, Ph.D.

Selected Publications

1)  Mejia-Garcia A, Sanchez-Ocampo EM, Galindo-Gomez S, Shibayama M, Reyes-Hernandez O, Guzman-Leon S, Gonzalez FJ, Elizondo G.
2,3,7,8-Tetrachlorodibenzo-p-dioxin enhances CCl4-induced hepatotoxicity in an aryl hydrocarbon receptor-dependent manner.
Xenobiotica. 43: 161-8, 2013.
[Journal]
2)  Albrecht PP, Torsell NE, Krishnan P, Ehresman DJ, Frame SR, Chang SC, Butenhoff JL, Kennedy GL, Gonzalez FJ, Peters JM.
A species difference in the peroxisome proliferator-activated receptor a-dependent response to the developmental effects of perfluorooctanoic acid.
Toxicol. Sci. 131: 568-82, 2013.
[Journal]
3)  Wejksza K, Lee-Chang C, Bodogai M, Bonzo J, Gonzalez FJ, Lehrmann E, Becker K, Biragyn A.
Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor a.
J. Immunol. 190: 2575-84, 2013.
[Journal]
4)  Cheng J, Krausz KW, Li F, Ma X, Gonzalez FJ.
CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid.
Toxicol. Appl. Pharmacol. 266: 245-53, 2013.
[Journal]
5)  Johnson CH, Bonzo JA, Cheng J, Krausz KW, Kang DW, Luecke H, Idle JR, Gonzalez FJ.
Cytochrome P450 regulation by a-tocopherol in Pxr-null and PXR-humanized mice.
Drug Metab. Dispos. 41: 406-13, 2013.
[Journal]
6)  Matsubara T, Li F, Gonzalez FJ.
FXR signaling in the enterohepatic system.
Mol. Cell. Endocrinol. 368: 17-29, 2013.
[Journal]
7)  Li F, Lu J, Cheng J, Wang L, Matsubara T, Csanaky IL, Klaassen CD, Gonzalez FJ, Ma X.
Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy.
Nat. Med. 19: 418-20, 2013.
[Journal]
8)  Jiang C, Kim JH, Li F, Qu A, Gavrilova O, Shah YM, Gonzalez FJ.
Hypoxia-inducible factor 1a regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.
J. Biol. Chem. 288: 3844-57, 2013.
[Journal]
9)  Kim J, Yamaori S, Tanabe T, Johnson CH, Krausz KW, Kato S, Gonzalez FJ.
Implication of intestinal VDR deficiency in inflammatory bowel disease.
Biochim. Biophys. Acta. 1830: 2118-28, 2013.
[Journal]
10)  Montanez JE, Peters JM, Correll JB, Gonzalez FJ, Patterson AD.
Metabolomics: an essential tool to understand the function of peroxisome proliferator-activated receptor alpha.
Toxicol Pathol. 41: 410-8, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 4/10/2013.